Tag-Archive for ◊ cardiovascular/vascular ◊

• Tuesday, February 04th, 2014

Bard Announces $500 Million Share Repurchase Authorization MURRAY HILL, N.J.–(BUSINESS WIRE)–C. R. Bard, Inc. (NYSE:BCR) today announced that its Board of Directors has authorized the repurchase of up to $500 million of the company’s common stock. This new authorization is in addition to the approximately $55 million remaining under the Company’s prior authorization. Share repurchases […]

• Wednesday, January 29th, 2014

Negative Pressure Wound Therapy helps reduce infections and other surgical complications, according to a clinical review published by a Smith & Nephew-funded expert panel. Smith & Nephew (FTSE:SN, NYSE:SNN) touted the outcomes of a clinical study review, reporting that Negative Pressure Wound Therapy proved effective in reducing complications when applied to surgical wounds for a few […]

• Tuesday, January 21st, 2014

St. Jude Medical quietly accepts FDA premarket approval for its Cool Flex ablation catheter and ablation generator for treatment of arrhythmia. Medtech titan St. Jude Medical (NYSE:STJ) won FDA premarket approval for its Cool Flex cardiac ablation system with indication to treat irregular heart rhythms. St. Jude accepted the win quietly, with not announcements listed on its site […]

• Tuesday, January 21st, 2014

Boston Scientific Corp. (BSX) won’t begin a study of its hypertension treatment until it can analyze a failed effort by Medtronic Inc. (MDT) and review its approach with U.S. regulators, Chief Executive Officer Michael Mahoney said. While Boston Scientific has Food and Drug Administration backing to start a pivotal trial of its Vessix technology, the company is waiting […]

• Wednesday, December 11th, 2013

NEW YORK, Dec. 5, 2013 — /PRNewswire/ — JARVIK HEART, Inc., a privately-held company that develops and manufactures cardiac assist devices, announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval to the Shonin (or pre-market approval) application submitted by Century Medical, Inc., (CMI) for the Jarvik 2000 Heart, a small Left […]

• Wednesday, December 11th, 2013

Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER Stent System NATICK, Mass. and PARSIPPANY, N.J., Dec. 6, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) and The Medicines Company (NASDAQ: MDCO) announce a co-promotion agreement for the Boston Scientific Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System. Under the terms of the agreement, The […]

• Friday, December 06th, 2013

AngioDynamics Announces Operational Excellence Program ALBANY, N.Y., Dec 05, 2013 (GLOBE NEWSWIRE via COMTEX) — AngioDynamics ANGO +1.50% , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today a Company-wide operational excellence program designed to save $15 million to $18 million during the course […]

• Friday, December 06th, 2013

Medtronic’s cardiac and vascular group president, Michael Coyle, questions CardioMEMS’ implantable heart monitor, citing Medtronic’s experience with its now-abandoned Chronicle monitor. The Champion implantable heart monitor made by CardioMEMS might not prove as cost-effective as a non-invasive approach, at least according to Medtronic (NYSE:MDT) cardiac and vascular group president Michael Coyle. Coyle, speaking at the 25th Annual […]

• Thursday, December 05th, 2013

Dec. 3, 2013 — Certain HeartStart automated external defibrillator (AED) devices made by Philips Medical Systems, a division of Philips Healthcare, may be unable to deliver needed defibrillator shock in a cardiac emergency situation, the U.S. Food and Drug Administration said today in a new safety communication for users of these previously recalled devices. The […]

• Monday, December 02nd, 2013

HeartWare International Announces Acquisition Of CircuLite, Inc. FRAMINGHAM, Mass. and TEANECK, N.J., Dec. 1, 2013 /PRNewswire/ — HeartWare International, Inc. (HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has acquired CircuLite, Inc. – developer of the SYNERGY Circulatory Support […]